ANAB
Price
$18.51
Change
-$0.78 (-4.04%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
590.64M
31 days until earnings call
SPRY
Price
$12.77
Change
-$0.63 (-4.70%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
1.32B
42 days until earnings call
Ad is loading...

ANAB vs SPRY

Header iconANAB vs SPRY Comparison
Open Charts ANAB vs SPRYBanner chart's image
AnaptysBio
Price$18.51
Change-$0.78 (-4.04%)
Volume$18.2K
Capitalization590.64M
ARS Pharmaceuticals
Price$12.77
Change-$0.63 (-4.70%)
Volume$93.91K
Capitalization1.32B
ANAB vs SPRY Comparison Chart
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. SPRY commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Buy and SPRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (ANAB: $19.29 vs. SPRY: $13.40)
Brand notoriety: ANAB and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 79% vs. SPRY: 161%
Market capitalization -- ANAB: $590.64M vs. SPRY: $1.32B
ANAB [@Biotechnology] is valued at $590.64M. SPRY’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRY is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • ANAB’s TA Score: 6 bullish, 2 bearish.
  • SPRY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than SPRY.

Price Growth

ANAB (@Biotechnology) experienced а +3.43% price change this week, while SPRY (@Biotechnology) price change was +6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

ANAB is expected to report earnings on May 08, 2025.

SPRY is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.32B) has a higher market cap than ANAB($591M). ANAB YTD gains are higher at: 45.695 vs. SPRY (27.014). SPRY has higher annual earnings (EBITDA): -3.08M vs. ANAB (-92.74M). ANAB has more cash in the bank: 385M vs. SPRY (314M). SPRY has less debt than ANAB: SPRY (42K) vs ANAB (16M). ANAB (91.3M) and SPRY (89.1M) have equivalent revenues.
ANABSPRYANAB / SPRY
Capitalization591M1.32B45%
EBITDA-92.74M-3.08M3,008%
Gain YTD45.69527.014169%
P/E RatioN/A167.75-
Revenue91.3M89.1M102%
Total Cash385M314M123%
Total Debt16M42K38,095%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABSPRY
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
88%
Momentum
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
79%
MACD
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 6 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
74%
Aroon
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 6 days ago
89%
View a ticker or compare two or three
Ad is loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+1.69%
CLRB - ANAB
45%
Loosely correlated
-2.95%
ADCT - ANAB
40%
Loosely correlated
-7.52%
HRMY - ANAB
38%
Loosely correlated
-4.80%
SPRY - ANAB
34%
Loosely correlated
+2.68%
IBRX - ANAB
34%
Loosely correlated
-2.62%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with ANAB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then ANAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+2.68%
ANAB - SPRY
35%
Loosely correlated
+1.69%
KRYS - SPRY
35%
Loosely correlated
-1.59%
ACLX - SPRY
34%
Loosely correlated
-7.12%
KROS - SPRY
33%
Loosely correlated
+2.39%
IMNM - SPRY
32%
Poorly correlated
-7.00%
More